Advances in technology and science have rapidly altered the biotechnology product landscape. What's more, the complexity of the regulatory system can make it difficult for citizens to understand how the safety of biotech products is evaluated. To ensure public confidence and help small and mid-size businesses navigate the regulatory process, the administration has proposed an update to the Coordinated Framework for the Regulation of Biotechnology.
Advertisement
"The proposed update offers the public